Smart Boot Use to Measure Offloading Adherence
Primary Purpose
Diabetic Foot Ulcer
Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Boot
Sponsored by
About this trial
This is an interventional treatment trial for Diabetic Foot Ulcer
Eligibility Criteria
Inclusion Criteria:
- Male or Female aged 18 or older
- Diabetic Foot Ulcer requiring offloading
- Able to provide written informed consent
Exclusion Criteria:
- Wound present for more than one year
- HbA1c > 12%
- Ankle Brachial Index (ABI) of index limb is <0.9 and/or they are being considered for revascularization within the course of the study
- Ulcer involving bone or tendon
- Ulcer not caused by diabetes
- Unable or unwilling to attend prescribed clinic visits
- Fully confined to a wheelchair
Sites / Locations
- Rancho Los Amigos National Rehabilitation CenterRecruiting
- Verdugo Hills Hospital of USCRecruiting
- Clemente Clinical ResearchRecruiting
- Keck Medical Center of USCRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Experimental
Arm Label
Smart boot irremovable
Smart boot removable
Smart boot removable+reinforcement
Arm Description
Smart boot rendered irremovable with cohesive bandage; no feedback on adherence.
Smart boot, removable, without feedback on adherence.
Smart boot with, removable, with reinforcement of adherence via smart watch and smart phone as well as remote patient monitoring.
Outcomes
Primary Outcome Measures
Wound healing
Percent healed
Adherence to offloading
Average daily hours of device wear during weight bearing activities, objectively measured using smart boot
Secondary Outcome Measures
Speed of wound healing
Measured as average weekly change in area of wound
Physical Activity
Measured by smart boot
Full Information
NCT ID
NCT04460573
First Posted
July 1, 2020
Last Updated
May 5, 2023
Sponsor
University of Southern California
Collaborators
Baylor College of Medicine
1. Study Identification
Unique Protocol Identification Number
NCT04460573
Brief Title
Smart Boot Use to Measure Offloading Adherence
Official Title
Improving the Science of Adherence Reinforcement and Safe Mobility in People With Diabetic Foot Ulcers Using Smart Offloading
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 19, 2021 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Southern California
Collaborators
Baylor College of Medicine
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of the treatment is to have the person wear a diabetic shoe or boot to help their foot heal. Sometimes people don't wear the boot like they are told. The investigators want to compare three different kinds of diabetic boots to see if they can help make it easier for people to wear their boots as instructed.
The investigators will look at three groups of participants: the first group will wear a boot that can't be taken off. The second group will wear a boot that can be taken off, and they will get counseling about how important it is to follow instructions as to how often and when to wear the boot. The third group will wear a "smart" boot, which will interact with the person through a smart watch and smart phone, and give them direct feedback about how they are doing with following their boot wearing prescription.
The investigators will also be looking at how much physical activity, like walking, the participants do. And they will compare how well participants sleep and rate their quality of life in the three different boots. The investigators think that giving participants information about how much they are wearing their boot using readily available technology will help them to follow the doctor's directions better, and help their wounds heal faster.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot Ulcer
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
prospective, comparative randomized trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
250 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Smart boot irremovable
Arm Type
Active Comparator
Arm Description
Smart boot rendered irremovable with cohesive bandage; no feedback on adherence.
Arm Title
Smart boot removable
Arm Type
Active Comparator
Arm Description
Smart boot, removable, without feedback on adherence.
Arm Title
Smart boot removable+reinforcement
Arm Type
Experimental
Arm Description
Smart boot with, removable, with reinforcement of adherence via smart watch and smart phone as well as remote patient monitoring.
Intervention Type
Device
Intervention Name(s)
Boot
Intervention Description
Smart boot in one of three configurations provided to participants
Primary Outcome Measure Information:
Title
Wound healing
Description
Percent healed
Time Frame
12 weeks
Title
Adherence to offloading
Description
Average daily hours of device wear during weight bearing activities, objectively measured using smart boot
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Speed of wound healing
Description
Measured as average weekly change in area of wound
Time Frame
12 weeks
Title
Physical Activity
Description
Measured by smart boot
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or Female aged 18 or older
Diabetic Foot Ulcer requiring offloading
Able to provide written informed consent
Exclusion Criteria:
Wound present for more than one year
HbA1c > 12%
Ankle Brachial Index (ABI) of index limb is <0.9 and/or they are being considered for revascularization within the course of the study
Ulcer involving bone or tendon
Ulcer not caused by diabetes
Unable or unwilling to attend prescribed clinic visits
Fully confined to a wheelchair
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jason Garcia, BA
Phone
323-680-0196
Email
Jason.garcia@med.usc.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Fabiola Rodriguez
Phone
323-516-2132
Email
fabiola.rodriguez@med.usc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David G Armstrong, DPN, MD, PhD
Organizational Affiliation
Professor of Surgery, Keck School of Medicine of USC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rancho Los Amigos National Rehabilitation Center
City
Downey
State/Province
California
ZIP/Postal Code
90242
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jason Garcia, BA
Phone
323-680-0196
Email
jason.garcia@med.usc.edu
Facility Name
Verdugo Hills Hospital of USC
City
Glendale
State/Province
California
ZIP/Postal Code
91208
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jason Garcia
Phone
323-680-0196
Email
jason.garcia@med.usc.edu
Facility Name
Clemente Clinical Research
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Scott Mathis
Phone
323-330-4287
Email
scott.mathis@clementeclinical.com
Facility Name
Keck Medical Center of USC
City
Los Angeles
State/Province
California
ZIP/Postal Code
90033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jason A Garcia, BA
Phone
323-680-0196
Email
jason.garcia@med.usc.edu
First Name & Middle Initial & Last Name & Degree
BA
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Individually identifiable data will be deleted or masked before being made available to individuals who are not a part of the study (research staff). Results released will be sufficiently aggregated as to make individual identification of subjects highly unlikely. When individual research subjects are identifiable using substitute unique identifiers (i.e., subject 10) the translation table will be safeguarded from release outside of the study staff.
Learn more about this trial
Smart Boot Use to Measure Offloading Adherence
We'll reach out to this number within 24 hrs